RC148 — Investigational Agent
Bispecific Antibody · Phase 1 · RemeGen
Mechanism of Action
RC148 is a PD-1 x VEGF bispecific antibody that simultaneously blocks PD-1 checkpoint signaling and sequesters VEGF, combining immune reactivation with anti-angiogenesis in a single molecule. It is studied as monotherapy and in ADC combinations for GI and other solid tumors.
Investigational Indications
- Gastric/GEJ adenocarcinoma
- Colorectal cancer
- Other advanced solid tumors